Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
placenta-derived gp96 injection
- Development stage
- Unknown
- Lead developer
- Boao Evergrande International Hospital
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Parenteral
01
Overview
Placenta-derived gp96 injection is an experimental biologic therapy being investigated for the treatment of amyotrophic lateral sclerosis (ALS). gp96, also known as heat shock protein 90 kDa beta member 1 (HSP90B1) or glucose-regulated protein 94 (GRP94), is a molecular chaperone located in the endoplasmic reticulum that plays a critical role in protein folding and the cellular stress response. In the context of ALS, this placenta-derived formulation is hypothesized to exert neuroprotective effects and modulate the immune system to slow disease progression. It is currently being evaluated in a Phase 0 clinical trial in China to assess safety and preliminary efficacy, with a focus on clinical symptom changes and immunological laboratory markers.
- Other names
- gp96 injectiongp-96 injectiongp 96 injectionplacenta-derived gp96
02
Targets
LRP1 (Prolow-density lipoprotein receptor-related protein 1)
Beyond the preview
Go deeper on placenta-derived gp96 injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on placenta-derived gp96 injection.